These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6897887)

  • 1. Prevention of amsacrine-induced phlebitis with heparin.
    Case DC
    Clin Pharm; 1982; 1(6):490. PubMed ID: 6897887
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of heparin to lower the incidence of phlebitis induced by anti-neoplastic agents used in ovarian cancer.
    Ikeda S; Douchi T; Nagata Y
    J Obstet Gynaecol Res; 2004 Dec; 30(6):427-9. PubMed ID: 15566456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some acquired facts apropos of the effectiveness of heparins in the prevention of postoperative phlebitis and pulmonary embolism].
    Boneu B
    Rev Prat; 1993 Jun; 43(11):1416-9. PubMed ID: 8235393
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute tumor lysis in T-cell leukemia induced by amsacrine.
    Vogler WR; Morris JG; Winton EF
    Arch Intern Med; 1983 Jan; 143(1):165-6. PubMed ID: 6600389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Venous protection of acute leukemia treatment with amsacrine].
    Ma XJ; Xiang YM; Hong J
    Zhonghua Hu Li Za Zhi; 1996 Sep; 31(9):506-7. PubMed ID: 9295513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of phlebitis: socioeconomic aspects. In defense of an old-fashioned method. Results of a survey on a national scale].
    Bourde C
    Phlebologie; 1984; 37(1):17-28. PubMed ID: 6718501
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of cephalothin-induced phlebitis.
    Welk PC; Campbell A
    Am J Hosp Pharm; 1977 Jun; 34(6):562, 564, 570. PubMed ID: 879173
    [No Abstract]   [Full Text] [Related]  

  • 8. QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine.
    Schwartz CL; Bender KS; Burke PJ; Kan JS; Civin CI
    Cancer Treat Rep; 1984; 68(7-8):1043-4. PubMed ID: 6547639
    [No Abstract]   [Full Text] [Related]  

  • 9. Effective prevention of chemotherapy--induced phlebitis by low-dose heparin: a prospective randomised trial.
    Thürlimann B; Bachmann I
    Ann Oncol; 1992 Apr; 3(4):311-3. PubMed ID: 1390306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiogram abnormalities induced by amsacrine.
    Weiss RB; Moquin D; Adams JD; Griffin JD; Zimbler H
    Cancer Chemother Pharmacol; 1983; 10(2):133-4. PubMed ID: 6572570
    [No Abstract]   [Full Text] [Related]  

  • 11. AMSA-induced seizures in patients with hypokalemia.
    Mittelman A; Arlin ZA
    Cancer Treat Rep; 1983 Jan; 67(1):102-3. PubMed ID: 6688555
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: Filtration and infusion phlebitis.
    Canada AT
    Am J Hosp Pharm; 1976 Mar; 33(3):212. PubMed ID: 1258877
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute myocardial necrosis during administration of amsacrine.
    Lindpaintner K; Lindpaintner LS; Wentworth M; Burns CP
    Cancer; 1986 Apr; 57(7):1284-6. PubMed ID: 3753891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulants in the prevention and treatment of postoperative venous complications].
    FAVRE-GILLY MJ; ITHIER S; BLANC MR; BOREL-MILHET MF; CROIZAT P; FROMENT R
    Lyon Med; 1953 Jan; 188(2):28-38; contd. PubMed ID: 13036256
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute ECG changes associated with AMSA treatment.
    Miller CF; Rajdev N
    Cancer Treat Rep; 1982 Aug; 66(8):1678-80. PubMed ID: 6896676
    [No Abstract]   [Full Text] [Related]  

  • 16. Prophylaxis against postinfusion phlebitis.
    Fonkalsrud EW; Carpenter K; Masuda JY; Beckerman JH
    Surg Gynecol Obstet; 1971 Aug; 133(2):253-6. PubMed ID: 5565353
    [No Abstract]   [Full Text] [Related]  

  • 17. Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip.
    Siegman-Igra Y; Jacobi E; Lang R; Schwartz D; Carmeli Y
    J Hosp Infect; 2005 Jun; 60(2):122-8. PubMed ID: 15866010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac arrhythmia associated with AMSA in a child: a Southwest Oncology Group Study.
    Riela AR; Kimball JC; Patterson RB
    Cancer Treat Rep; 1981; 65(11-12):1121-3. PubMed ID: 6945913
    [No Abstract]   [Full Text] [Related]  

  • 19. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent.
    Harrigan CA
    NITA; 1984; 7(6):478-82. PubMed ID: 6568460
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
    Von Hoff DD; Elson D; Polk G; Coltman C
    Cancer Treat Rep; 1980; 64(2-3):356-8. PubMed ID: 6931630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.